The Pattern of Myometrial Invasion as a Predictor of Lymph Node Metastasis or Extrauterine Disease in Low-grade Endometrial Carcinoma

被引:76
作者
Euscher, Elizabeth [1 ]
Fox, Patricia [1 ]
Bassett, Roland [1 ]
Al-Ghawi, Hayma [1 ]
Ali-Fehmi, Rouba [2 ]
Barbuto, Denise [3 ]
Djordjevic, Bojana [6 ]
Frauenhoffer, Elizabeth [4 ]
Kim, Insun [7 ]
Hong, Sun Rang [8 ]
Montiel, Delia [9 ]
Moschiano, Elizabeth [3 ]
Roma, Andres [5 ]
Silva, Elvio [1 ,3 ]
Malpica, Anais [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Wayne State Univ, Detroit, MI USA
[3] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[4] Penn State Univ, Hershey, PA USA
[5] Cleveland Clin, Cleveland, OH 44106 USA
[6] Univ Ottawa, Ottawa Hosp, Ottawa, ON, Canada
[7] Korea Univ, Anam Hosp, Seoul, South Korea
[8] Kwandong Hosp, Seoul, South Korea
[9] Inst Nacl Cancerol, Mexico City, DF, Mexico
关键词
low grade; endometrial; endometrioid; adenocarcinoma; myometrium; invasion; risk factors; lymph node; metastasis; recurrence; FROZEN-SECTION; RISK-FACTOR; ADENOCARCINOMA; CANCER; LYMPHADENECTOMY; DIFFERENTIATION; RECURRENCE; FREQUENCY; SURVIVAL; OUTCOMES;
D O I
10.1097/PAS.0b013e318299f2ab
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The purpose of this study was to examine predictors of lymph node (LN) metastases or extrauterine disease (ED) in low-grade (FIGO grade 1 or 2) endometrioid carcinoma (LGEC) in a multi-institutional setting. For LGEC with and without LN metastasis or ED, each of the 9 participating institutions evaluated patients' age, tumor size, myometrial invasion (MI), FIGO grade, % solid component, the presence or absence of papillary architecture, microcystic, elongated, and fragmented glands (MELF), single-cell/cell-cluster invasion (SCI), lymphovascular invasion (LVI), lower uterine segment (LUS) and cervical stromal (CX) involvement, and numbers of pelvic and para-aortic LNs sampled. A total of 304 cases were reviewed: LN+ or ED+, 96; LN-/ED-, 208. Patients' ages ranged from 23 to 91 years (median 61 y). Table 1 summarizes the histopathologic variables that were noted for the LN+ or ED+ group: tumor size >= 2 cm, 93/96 (97%); MI > 50%, 54/96 (56%); MELF, 67/96 (70%); SCI, 33/96 (34%); LVI, 79/96 (82%); > 20% solid, 65/96 (68%); papillary architecture present, 68/96 (72%); LUS involved, 64/96 (67%); and CX involved, 41/96 (43%). For the LN-/ED- group, the results were as follows: tumor size >= 2 cm, 152/208 (73%); MI > 50%, 56/208 (27%); MELF, 79/208 (38%); SCI, 19/208 (9%); LVI, 56/208 (27%); > 20% solid, 160/208 (77%); papillary architecture present, 122/208 (59%); LUS involved, 77/208 (37%); CX involved, 24/208 (12%). There was no evidence of a difference in the number of pelvic or para-aortic LNs sampled between groups (P = 0.9 and 0.1, respectively). After multivariate analysis, the depth ofMI, CX involvement, LVI, and SCI emerged as significant predictors of advanced-stage disease. Although univariate analysis pointed to LUS involvement, MELF pattern of invasion, and papillary architecture as possible predictors of advanced-stage disease, these were not shown to be significant by multivariate analysis. This study validates MI, CX involvement, and LVI as significant predictors of LN+ or ED+. The association of SCI pattern with advanced-stage LGEC is a novel finding.
引用
收藏
页码:1728 / 1736
页数:9
相关论文
共 42 条
[1]   The novel criteria for predicting pelvic lymph node metastasis in endometrioid adenocarcinoma of endometrium [J].
Akbayir, Ozgur ;
Corbacioglu, Aytul ;
Goksedef, B. Pinar Cilesiz ;
Numanoglu, Ceyhun ;
Akca, Aysu ;
Guraslan, Hakan ;
Bakir, Lale Vuslat ;
Cetin, Ahmet .
GYNECOLOGIC ONCOLOGY, 2012, 125 (02) :400-403
[2]  
AMBROS RA, 1994, AM J SURG PATHOL, V18, P569
[3]   The impact of surgical guidelines and periodic quality assessment on the staging of endometrial cancer [J].
Bakkum-Gamez, Jamie N. ;
Mariani, Andrea ;
Dowdy, Sean C. ;
Weaver, Amy L. ;
McGree, Michaela E. ;
Cliby, William A. ;
Gostout, Bobbie S. ;
Stanhope, C. Robert ;
Wilson, Timothy O. ;
Podratz, Karl C. .
GYNECOLOGIC ONCOLOGY, 2011, 123 (01) :58-64
[4]   The outcomes of 27,063 women with unstaged endometrioid uterine cancer [J].
Chan, John K. ;
Wu, Huahsi ;
Cheung, Michael K. ;
Shin, Jacob Y. ;
Osann, Kathryn ;
Kapp, Daniel S. .
GYNECOLOGIC ONCOLOGY, 2007, 106 (02) :282-288
[5]   Lymphadenectomy in endometrioid uterine cancer staging - How many lymph nodes are enough? A study of 11,443 patients [J].
Chan, John K. ;
Urban, Renata ;
Cheung, Michael K. ;
Shin, Jacob Y. ;
Husain, Amreen ;
Teng, Nelson N. ;
Berek, Jonathan S. ;
Walker, Joan L. ;
Kapp, Daniel S. ;
Osann, Kathryn .
CANCER, 2007, 109 (12) :2454-2460
[6]   Therapeutic role of lymph node resection in endometrioid corpus cancer - A study of 12,333 patients [J].
Chan, John K. ;
Cheung, Michael K. ;
Huh, Warner K. ;
Osann, Kathryn ;
Husain, Amreen ;
Teng, Nelson N. ;
Kapp, Daniel S. .
CANCER, 2006, 107 (08) :1823-1830
[7]   The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology [J].
Chi, D. S. ;
Barakat, R. R. ;
Palayekar, M. J. ;
Levine, D. A. ;
Sonoda, Y. ;
Alektiar, K. ;
Brown, C. L. ;
Abu-Rustum, N. R. .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2008, 18 (02) :269-273
[8]   Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer [J].
Cragun, JM ;
Havrilesky, LJ ;
Calingaert, B ;
Synan, I ;
Secord, AA ;
Soper, JT ;
Clarke-Pearson, DL ;
Berchuck, A .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) :3668-3675
[9]  
CREASMAN W T, 1976, Gynecologic Oncology, V4, P239, DOI 10.1016/0090-8258(76)90028-7
[10]  
CREASMAN WT, 1987, CANCER, V60, P2035, DOI 10.1002/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO